Q4 FY26 quarterly results (January-March 2026)

5,116 companies have declared Q4 FY26 results so far, the latest on 15 Oct 2026.

Across the 4,645 non-financial companies with a year-ago quarter to compare, sales grew +12.4% and net profit +34.1% year on year, and the combined operating margin widened 10 bps to 14.3%.

For the 120 banks and lenders, net interest income grew +9.1% and net profit +11.1%.

55% of companies grew net profit; 472 turned a loss into a profit; 38% beat their own profit trend and 48% fell short of it.

Updated 16 Oct 2026, 11:29 IST 5116 declared
The next results season has started: 111 companies have filed results for the quarter ended 30 Sep 2026. See them →

Q4 FY26 scoreboard

Sales growth
+12.4%
YoY, 4645 companies combined; median +11.7%
Net profit growth
+34.1%
YoY combined; median +16.1%
Operating margin
14.3%
+10 bps YoY
Grew profit
55%
472 turnarounds, 495 into loss
Vs own profit trend
38% / 48%
above / below, 14% in line
Banks: NII growth
+9.1%
120 lenders; profit +11.1%
Price since results
-5.6%
median; 28% of 36 stocks up
Other-income heavy
1375
25%+ of pre-tax profit from other income & one-offs

Latest Q4 FY26 results 5116

Page 119 of 171

Alufluoride Ltd

524634 · Q4 FY26 · Consolidated
M Cap
—
P/E
—
PEG
—
  • Profit +210% above its own trend
  • Operating margin expanded 999 bps YoY
  • Core business grew faster than reported profit (core profit +243%)
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales -4.5%-11.9% 51.658.654.0
Operating profit +101.9%-30.2% 9.814.04.8
OPM % +999 bps-496 bps 19.0%23.9%9.0%
Other income to lossto loss -0.51.10.6
Net profit? +211.3%-50.5% 4.79.41.5
PAT margin % +627 bps-704 bps 9.1%16.1%2.8%
EPS (₹) +210.9%-50.5% 5.9712.061.92

Quality of profit

Pre-tax profit ₹6.2 Cr: core business ₹6.7 Cr, other income −₹0.5 Cr.

Core profit YoY: +243.4% · reported profit +211.3%

Cash & debt

FY26 cash from operations ₹47.0 Cr: 187% of FY26 net profit of ₹25.1 Cr.

Borrowings ₹45.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹65.1₹51.6 -20.8% below
Net profit₹1.5₹4.7 +209.7% above

Oxygenta Pharmaceutical Ltd

524636 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Operating margin expanded 364 bps YoY
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +0.3%+46.2% 49.633.949.5
Operating profit from lossfrom loss 0.1-4.1-1.7
OPM % +364 bps+1227 bps 0.2%-12.0%-3.4%
Other income from loss— 0.20.0-0.2
Net profit loss narrowedloss narrowed -1.7-4.8-2.1
PAT margin % +92 bps+1084 bps -3.4%-14.3%-4.3%
EPS (₹) loss narrowedloss narrowed -0.46-1.31-0.58

Quality of profit

Pre-tax profit −₹1.3 Cr: core business −₹1.4 Cr, other income ₹0.2 Cr.

Core profit YoY: loss narrowed

Cash & debt

FY26 cash from operations −₹28.0 Cr.

Borrowings ₹110 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹54.9₹49.6 -9.7% below

Archit Organosys Ltd

524640 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Profit -43% below its own trend
  • Operating margin expanded 316 bps YoY
  • Core business grew faster than reported profit (core profit +31%)
  • FY26 operating cash flow was only 37% of profit
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales -15.5%-4.9% 36.538.443.2
Operating profit +10.6%+4.5% 4.94.74.4
OPM % +316 bps+121 bps 13.4%12.2%10.2%
Other income to lossto loss -0.50.91.1
Net profit +0.0%-16.9% 2.02.42.0
PAT margin % +86 bps-79 bps 5.5%6.3%4.7%
EPS (₹) +0.0%-16.9% 0.981.180.98

Quality of profit

Pre-tax profit ₹2.5 Cr: core business ₹2.9 Cr, other income −₹0.5 Cr.

Core profit YoY: +30.7% · reported profit +0.0%

Cash & debt

FY26 cash from operations ₹3.0 Cr: 37% of FY26 net profit of ₹8.0 Cr.

Borrowings ₹25.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹56.6₹36.5 -35.5% below
Net profit₹3.6₹2.0 -43.3% below

Sikozy Realtors Ltd

524642 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales —-100.0% 0.00.10.0
Operating profit loss widenedloss widened -0.1-0.0-0.0
Other income —— 0.00.00.0
Net profit loss widenedloss widened -0.1-0.1-0.1
EPS (₹) loss widenedloss widened -0.03-0.02-0.01

Quality of profit

Pre-tax profit −₹0.1 Cr: core business −₹0.1 Cr, other income ₹0.0 Cr.

Core profit YoY: loss widened

Cash & debt

FY26 cash from operations ₹0.0 Cr.

Borrowings ₹0.5 Cr at Mar 2026.

Welcure Drugs & Pharmaceuticals Ltd

524661 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Into loss: a profit a year ago
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales -100.0%— 0.00.021.0
Operating profit to loss— -50.00.01.0
Other income -100.0%-100.0% 0.01.02.0
Net profit to lossto loss -50.01.03.0
EPS (₹) to lossto loss adj. -0.36adj. 0.010.02

EPS restated for the 1:10 bonus of Oct 2025: Mar 2026 ₹-0.40 to ₹-0.36; Dec 2025 ₹0.01 to ₹0.01.

Quality of profit

Pre-tax profit −₹50.0 Cr: core business −₹50.0 Cr, other income ₹0.0 Cr.

Core profit YoY: to loss

Cash & debt

FY26 cash from operations ₹2.0 Cr.

Borrowings nil at Mar 2026.

Kabsons Industries Ltd

524675 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +10.4%+2.1% 11.211.010.2
Operating profit -19.0%-77.3% 0.20.80.2
OPM % -55 bps-530 bps 1.5%6.8%2.1%
Other income to lossto loss -0.20.20.1
Net profit loss widenedto loss -0.60.6-0.0
PAT margin % -542 bps-1087 bps -5.5%5.4%-0.1%
EPS (₹) loss widenedto loss -0.360.34-0.01

Quality of profit

Pre-tax profit −₹0.4 Cr: core business −₹0.2 Cr, other income −₹0.2 Cr.

Core profit YoY: loss widened

Cash & debt

FY26 cash from operations ₹2.2 Cr: 275% of FY26 net profit of ₹0.8 Cr.

Borrowings ₹0.3 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹10.9₹11.2 +3.3% in line

Basant Agro Tech India Ltd

524687 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Operating cash flow was negative in FY26 despite a profit
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +22.9%+32.5% 163123133
Operating profit +8.0%+29.8% 8.96.98.3
OPM % -76 bps-12 bps 5.5%5.6%6.2%
Other income +640.0%— 0.40.00.1
Net profit +92.2%+76.8% 2.21.21.1
PAT margin % +49 bps+34 bps 1.4%1.0%0.9%
EPS (₹) +84.6%+71.4% 0.240.140.13

Quality of profit

Core 93%Other income & one-offs 7%

Pre-tax profit ₹5.0 Cr: core business ₹4.6 Cr, other income ₹0.4 Cr.

Core profit YoY: +28.6% · reported profit +92.2%

Cash & debt

FY26 cash from operations −₹34.0 Cr: -489% of FY26 net profit of ₹7.0 Cr.

Borrowings ₹184 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹172₹163 -5.2% below
Net profit₹2.3₹2.2 -3.5% in line

Sandu Pharmaceuticals Ltd

524703 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Profit -90% below its own trend
  • 49% of pre-tax profit came from other income and one-off items
  • Core business grew faster than reported profit (core profit +41%)
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +19.8%-10.2% 16.918.814.1
Operating profit +26.7%-45.2% 0.61.00.5
OPM % +18 bps-216 bps 3.4%5.5%3.2%
Other income +428.6%— 0.40.00.1
Net profit -87.9%-95.9% 0.01.00.3
PAT margin % -211 bps-499 bps 0.2%5.2%2.3%
EPS (₹) -88.2%-96.0% 0.041.010.34

Quality of profit

Core 51%Other income & one-offs 49%

Pre-tax profit ₹0.8 Cr: core business ₹0.4 Cr, other income ₹0.4 Cr.

Core profit YoY: +40.7% · reported profit -87.9%

Cash & debt

FY26 cash from operations ₹6.1 Cr: 348% of FY26 net profit of ₹1.8 Cr.

Borrowings ₹0.4 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹13.9₹16.9 +21.3% above
Net profit₹0.4₹0.0 -89.6% below

Vista Pharmaceuticals Ltd

524711 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales -100.0%-100.0% 0.02.43.2
Operating profit loss widenedloss widened -7.1-3.0-0.9
Other income -87.5%-66.7% 0.00.10.2
Net profit loss widenedloss widened -5.9-2.3-1.5
EPS (₹) loss widenedloss widened -0.95-0.38-0.41

Quality of profit

Pre-tax profit −₹7.8 Cr: core business −₹7.8 Cr, other income ₹0.0 Cr.

Core profit YoY: loss widened

Cash & debt

FY26 cash from operations −₹4.0 Cr.

Borrowings ₹10.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹2.9₹0.0 -100.0% below

Titan Biotech Ltd

524717 · Q4 FY26 · Consolidated
M Cap
—
P/E
—
PEG
—
  • Profit +49% above its own trend
  • Operating margin expanded 689 bps YoY
  • Core business grew faster than reported profit (core profit +124%)
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +38.8%-13.6% 48.856.535.2
Operating profit +112.5%-10.3% 9.710.84.6
OPM % +689 bps+72 bps 19.9%19.2%13.0%
Other income +52.9%+67.5% 2.11.31.4
Net profit? +66.2%-21.1% 6.78.54.0
PAT margin % +227 bps-131 bps 13.8%15.1%11.5%
EPS (₹) +66.3%-21.3% 1.632.070.98

Quality of profit

Core 80%Other income & one-offs 20%

Pre-tax profit ₹10.3 Cr: core business ₹8.2 Cr, other income ₹2.1 Cr.

Core profit YoY: +123.8% · reported profit +66.2%

Cash & debt

FY26 cash from operations ₹30.0 Cr: 100% of FY26 net profit of ₹29.9 Cr.

Borrowings ₹6.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹42.9₹48.8 +13.8% above
Net profit₹4.5₹6.7 +49.0% above

Arvaya Healthcare Ltd

524723 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales —— 0.00.00.0
Operating profit loss widenedloss widened -0.7-0.2-0.2
Other income +40.0%+40.0% 0.10.10.1
Net profit loss widenedloss widened -0.6-0.2-0.2
EPS (₹) loss narrowedloss narrowed -0.13-0.21-0.70

Quality of profit

Pre-tax profit −₹0.6 Cr: core business −₹0.7 Cr, other income ₹0.1 Cr.

Core profit YoY: loss widened

Cash & debt

FY26 cash from operations −₹7.9 Cr.

Borrowings ₹2.5 Cr at Mar 2026.

Span Divergent Ltd

524727 · Q4 FY26 · Consolidated
M Cap
—
P/E
—
PEG
—
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +745.5%+20.5% 4.73.90.6
Operating profit loss narrowedloss narrowed -0.9-1.1-0.9
OPM % —+948 bps -18.5%-28.0%—
Other income -55.9%-55.9% 0.10.30.3
Net profit? loss widenedloss narrowed -1.1-1.1-1.0
PAT margin % —+519 bps -24.1%-29.3%—
EPS (₹) loss narrowedloss narrowed -1.32-1.78-1.63

Quality of profit

Pre-tax profit −₹1.1 Cr: core business −₹1.3 Cr, other income ₹0.1 Cr.

Core profit YoY: loss narrowed

Cash & debt

FY26 cash from operations ₹0.2 Cr.

Borrowings ₹7.1 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹0.6₹4.7 +628.8% above

Jenburkt Pharmaceuticals Ltd

524731 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Profit +15% above its own trend
  • Operating margin expanded 428 bps YoY
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +9.8%+4.7% 45.043.041.0
Operating profit +27.3%+100.0% 14.07.011.0
OPM % +428 bps+1483 bps 31.1%16.3%26.8%
Other income -100.0%-100.0% 0.02.02.0
Net profit +22.2%+83.3% 11.06.09.0
PAT margin % +249 bps+1049 bps 24.4%14.0%22.0%
EPS (₹) +27.0%+82.9% 24.5813.4419.35

Quality of profit

Core 93%Other income & one-offs 7%

Pre-tax profit ₹14.0 Cr: core business ₹13.0 Cr, other income ₹0.0 Cr, exceptional & other items ₹1.0 Cr.

Core profit YoY: +30.0% · reported profit +22.2%

Cash & debt

FY26 cash from operations ₹27.0 Cr: 77% of FY26 net profit of ₹35.0 Cr.

Borrowings ₹2.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹45.4₹45.0 -0.8% in line
Net profit₹9.6₹11.0 +15.0% above

Link Pharma Chem Ltd

524748 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +2.2%-2.1% 6.66.76.5
Operating profit loss widenedto loss -0.20.7-0.2
OPM % -8 bps-1389 bps -3.6%10.3%-3.6%
Other income +25.0%from loss 0.1-0.20.1
Net profit loss widenedto loss -0.40.1-0.3
PAT margin % -80 bps-726 bps -6.2%1.0%-5.4%
EPS (₹) loss widenedto loss -0.920.16-0.79

Quality of profit

Pre-tax profit −₹0.5 Cr: core business −₹0.6 Cr, other income ₹0.1 Cr.

Core profit YoY: loss widened

Cash & debt

FY26 cash from operations ₹2.1 Cr: 2687% of FY26 net profit of ₹0.1 Cr.

Borrowings ₹7.3 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹6.9₹6.6 -4.6% in line

Decipher Labs Ltd

524752 · Q4 FY26 · Consolidated
M Cap
—
P/E
—
PEG
—
  • 68% of pre-tax profit came from other income and one-off items
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +2.9%+12.1% 3.63.23.5
Operating profit from lossfrom loss 0.2-0.4-6.6
OPM % —+1978 bps 6.4%-13.4%—
Other income -80.5%+750.0% 0.20.00.9
Net profit? loss narrowedloss narrowed -0.4-0.5-4.1
PAT margin % —+682 bps -10.0%-16.8%—
EPS (₹) loss narrowedloss narrowed -0.36-0.53-4.07

Quality of profit

Core 32%Other income & one-offs 68%

Pre-tax profit ₹0.2 Cr: core business ₹0.1 Cr, other income ₹0.2 Cr.

Core profit YoY: from loss

Cash & debt

FY26 cash from operations −₹2.1 Cr.

Borrowings ₹0.5 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹1.8₹3.6 +105.7% above

Emmessar Biotech & Nutrition Ltd

524768 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Turnaround: profit against a loss a year ago
  • All of pre-tax profit came from other income or one-off items
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales -10.0%+0.0% 0.10.10.1
Operating profit loss widenedloss widened -0.4-0.3-0.3
Other income -23.0%-4.1% 0.50.50.6
Net profit from loss-75.0% 0.00.1-0.1
PAT margin % +10333 bps— 33.3%—-70.0%
EPS (₹) from loss-75.0% 0.060.24-0.14

Quality of profit

Pre-tax profit ₹0.1 Cr: core business −₹0.4 Cr, other income ₹0.5 Cr.

Core profit YoY: loss widened

Cash & debt

FY26 cash from operations ₹0.3 Cr: 63% of FY26 net profit of ₹0.4 Cr.

Borrowings nil at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹0.1₹0.1 -11.1% below

Everest Organics Ltd

524790 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Profit -42% below its own trend
  • Operating margin expanded 534 bps YoY
  • Core business grew faster than reported profit (core profit +175%)
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +19.1%+14.5% 48.842.640.9
Operating profit +94.8%+89.3% 6.73.53.4
OPM % +534 bps+543 bps 13.7%8.3%8.4%
Other income -27.3%-36.0% 0.20.20.2
Net profit -9.6%+630.6% 2.60.42.9
PAT margin % -171 bps+455 bps 5.4%0.8%7.1%
EPS (₹) -9.7%+632.4% 2.710.373.00

Quality of profit

Core 93%Other income & one-offs 7%

Pre-tax profit ₹2.2 Cr: core business ₹2.0 Cr, other income ₹0.2 Cr.

Core profit YoY: +175.3% · reported profit -9.6%

Cash & debt

FY26 cash from operations ₹4.0 Cr: 72% of FY26 net profit of ₹5.6 Cr.

Borrowings ₹50.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹44.4₹48.8 +9.7% above
Net profit₹4.6₹2.6 -42.3% below

Phyto Chem India Ltd

524808 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales -84.2%-92.3% 0.23.01.5
Operating profit loss narrowedloss widened -0.7-0.2-1.1
Other income +60.8%+164.5% 0.80.30.5
Net profit loss narrowedloss narrowed -0.3-0.5-1.2
EPS (₹) loss narrowedloss narrowed -0.65-1.12-2.70

Quality of profit

Pre-tax profit −₹0.3 Cr: core business −₹1.1 Cr, other income ₹0.8 Cr.

Core profit YoY: loss narrowed

Cash & debt

FY26 cash from operations ₹0.9 Cr.

Borrowings ₹20.5 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹1.3₹0.2 -82.6% below

Dynamic Industries Ltd

524818 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Profit -45% below its own trend
  • 35% of pre-tax profit came from other income and one-off items
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales -8.7%+22.9% 17.314.119.0
Operating profit -7.5%+56.3% 1.40.91.5
OPM % +10 bps+168 bps 7.8%6.2%7.7%
Other income +163.6%+866.7% 0.30.00.1
Net profit -7.5%— 0.60.10.7
PAT margin % +5 bps+322 bps 3.6%0.4%3.5%
EPS (₹) -7.2%— 2.050.172.21

Quality of profit

Core 65%Other income & one-offs 35%

Pre-tax profit ₹0.8 Cr: core business ₹0.5 Cr, other income ₹0.3 Cr.

Core profit YoY: -5.3% · reported profit -7.5%

Cash & debt

FY26 cash from operations ₹6.4 Cr: 350% of FY26 net profit of ₹1.8 Cr.

Borrowings ₹13.8 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹21.0₹17.3 -17.4% below
Net profit₹1.1₹0.6 -44.9% below

BDH Industries Ltd

524828 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Operating margin contracted 273 bps YoY
  • Core business grew faster than reported profit (core profit +41%)
  • Operating cash flow was negative in FY26 despite a profit
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +62.9%-1.1% 29.029.317.8
Operating profit +37.1%-0.5% 4.24.23.1
OPM % -273 bps+9 bps 14.5%14.4%17.2%
Other income +7.0%+15.1% 0.60.50.6
Net profit +15.7%-17.5% 2.93.52.5
PAT margin % -405 bps-197 bps 9.9%11.9%14.0%
EPS (₹) +15.7%-17.5% 5.006.064.32

Quality of profit

Core 87%Other income & one-offs 13%

Pre-tax profit ₹4.6 Cr: core business ₹4.0 Cr, other income ₹0.6 Cr.

Core profit YoY: +40.6% · reported profit +15.7%

Cash & debt

FY26 cash from operations −₹2.0 Cr: -18% of FY26 net profit of ₹10.8 Cr.

Borrowings ₹2.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹20.6₹29.0 +40.8% above
Net profit₹2.8₹2.9 +2.7% in line

Jauss Polymers Ltd

526001 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Into loss: a profit a year ago
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales —— 0.00.00.0
Operating profit loss widenedloss narrowed -0.4-4.6-0.0
Other income -100.0%— 0.00.00.1
Net profit to lossloss narrowed -0.4-4.60.1
EPS (₹) to lossloss narrowed -0.86-9.880.24

Quality of profit

Pre-tax profit −₹0.4 Cr: core business −₹0.4 Cr, other income ₹0.0 Cr.

Core profit YoY: loss widened

Cash & debt

Borrowings nil at Mar 2026.

Globus Constructors & Developers Ltd

526025 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Into loss: a profit a year ago
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales —— 0.00.00.0
Operating profit —loss narrowed -0.1-0.1-0.1
Other income -98.0%-33.3% 0.10.14.0
Net profit to loss— -0.0-0.03.9
EPS (₹) -100.0%— 0.000.000.40

Quality of profit

Pre-tax profit −₹0.0 Cr: core business −₹0.1 Cr, other income ₹0.1 Cr.

Cash & debt

FY26 cash from operations ₹0.0 Cr.

Borrowings nil at Mar 2026.

Polymechplast Machines Ltd

526043 · Q4 FY26 · Consolidated
M Cap
—
P/E
—
PEG
—
  • Profit +844% above its own trend
  • Operating margin contracted 369 bps YoY
  • All of pre-tax profit came from other income or one-off items
  • Operating cash flow was negative in FY26 despite a profit
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +13.4%+7.5% 21.820.219.2
Operating profit to lossto loss -0.31.10.4
OPM % -369 bps-705 bps -1.6%5.4%2.1%
Other income —— 4.30.20.2
Net profit? —+388.5% 3.00.60.2
PAT margin % +1266 bps+1069 bps 13.7%3.0%1.0%
EPS (₹) —+388.1% 5.321.090.36

Quality of profit

Pre-tax profit ₹3.6 Cr: core business −₹0.7 Cr, other income ₹4.3 Cr.

Core profit YoY: to loss

Cash & debt

FY26 cash from operations −₹5.2 Cr: -163% of FY26 net profit of ₹3.2 Cr.

Borrowings ₹4.7 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹19.1₹21.8 +13.9% above
Net profit₹0.3₹3.0 +843.8% above

Stellant Securities (India) Ltd

526071 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Operating cash flow was negative in FY26 despite a profit
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales —+500.0% 6.01.00.0
Operating profit —loss widened -7.0-6.00.0
Other income —— 0.00.00.0
Net profit —— -5.0-5.00.0
PAT margin % —— -83.3%——
EPS (₹) to lossloss narrowed -9.01-12.530.10

Quality of profit

Pre-tax profit −₹6.0 Cr: core business −₹7.0 Cr, other income ₹0.0 Cr, exceptional & other items ₹1.0 Cr.

Cash & debt

FY26 cash from operations −₹19.0 Cr: -90% of FY26 net profit of ₹21.0 Cr.

Borrowings nil at Mar 2026.

Galaxy Bearings Ltd

526073 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Profit -67% below its own trend
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales -30.5%+41.7% 20.814.729.9
Operating profit -33.1%+192.1% 4.41.56.6
OPM % -83 bps+1090 bps 21.2%10.3%22.0%
Other income loss widenedto loss -2.21.8-0.1
Net profit -73.9%-39.7% 1.11.84.1
PAT margin % -864 bps-699 bps 5.2%12.2%13.8%
EPS (₹) -73.9%-39.6% 3.405.6313.02

Quality of profit

Pre-tax profit ₹1.3 Cr: core business ₹3.4 Cr, other income −₹2.2 Cr.

Core profit YoY: -40.4% · reported profit -73.9%

Cash & debt

FY26 cash from operations ₹19.8 Cr: 598% of FY26 net profit of ₹3.3 Cr.

Borrowings ₹18.1 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹22.6₹20.8 -7.9% below
Net profit₹3.2₹1.1 -66.6% below

Rekvina Laboratories Ltd

526075 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales —+105.7% 0.70.30.0
Operating profit loss widenedloss narrowed -0.1-0.1-0.0
OPM % —+2595 bps -8.3%-34.3%—
Other income —— 0.00.00.0
Net profit loss widenedloss narrowed -0.1-0.1-0.0
PAT margin % —+2595 bps -8.3%-34.3%—
EPS (₹) loss widenedloss narrowed -0.05-0.10-0.03

Quality of profit

Pre-tax profit −₹0.1 Cr: core business −₹0.1 Cr, other income ₹0.0 Cr.

Core profit YoY: loss widened

Cash & debt

FY26 cash from operations −₹0.6 Cr.

Borrowings ₹1.5 Cr at Mar 2026.

SC Agrotech Ltd

526081 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Turnaround: profit against a loss a year ago
  • Operating cash flow was negative in FY26 despite a profit
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales —+15.4% 43.437.60.0
Operating profit from loss-81.6% 0.73.7-0.9
OPM % —-828 bps 1.6%9.9%—
Other income -100.0%— 0.00.00.1
Net profit from loss-86.1% 0.42.7-0.8
PAT margin % —-639 bps 0.9%7.3%—
EPS (₹) from loss-94.9% 0.050.98-1.25

Quality of profit

Core 100%Other income & one-offs 0%

Pre-tax profit ₹0.7 Cr: core business ₹0.7 Cr, other income ₹0.0 Cr.

Core profit YoY: from loss

Cash & debt

FY26 cash from operations −₹122 Cr: -3654% of FY26 net profit of ₹3.3 Cr.

Borrowings ₹10.1 Cr at Mar 2026.

Ravileela Granites Ltd

526095 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Turnaround: profit against a loss a year ago
  • Operating margin expanded 1462 bps YoY
  • 41% of pre-tax profit came from other income and one-off items
  • Operating cash flow was negative in FY26 despite a profit
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +40.1%+149.2% 22.79.116.2
Operating profit —+173.5% 3.61.30.2
OPM % +1462 bps+141 bps 15.9%14.5%1.3%
Other income +483.3%+230.2% 1.80.50.3
Net profit from loss— 3.90.3-0.2
PAT margin % +1857 bps+1429 bps 17.2%2.9%-1.4%
EPS (₹) from loss— 3.670.25-0.22

Quality of profit

Core 59%Other income & one-offs 41%

Pre-tax profit ₹4.2 Cr: core business ₹2.5 Cr, other income ₹1.8 Cr.

Core profit YoY: from loss

Cash & debt

FY26 cash from operations −₹5.5 Cr: -55% of FY26 net profit of ₹9.9 Cr.

Borrowings ₹58.0 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹24.8₹22.7 -8.5% below

Uniroyal Marine Exports Ltd

526113 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
  • Operating margin contracted 2539 bps YoY
  • All of pre-tax profit came from other income or one-off items
  • Operating cash flow was negative in FY26 despite a profit
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales +126.5%+213.8% 14.14.56.2
Operating profit -90.3%-62.8% 0.20.41.6
OPM % -2539 bps-844 bps 1.1%9.6%26.5%
Other income +80.0%+800.0% 0.10.00.1
Net profit -99.1%-75.0% 0.00.01.1
PAT margin % -1697 bps-82 bps 0.1%0.9%17.0%
EPS (₹) -98.8%-66.7% 0.020.061.64

Quality of profit

Pre-tax profit ₹0.0 Cr: core business −₹0.1 Cr, other income ₹0.1 Cr.

Core profit YoY: to loss · reported profit -99.1%

Cash & debt

FY26 cash from operations −₹0.5 Cr: -174% of FY26 net profit of ₹0.3 Cr.

Borrowings ₹16.5 Cr at Mar 2026.

Against its own trend ?

TrendActualGap
Sales₹6.2₹14.1 +128.3% above

Karan Woo Sin Ltd

526115 · Q4 FY26 · Standalone
M Cap
—
P/E
—
PEG
—
₹ CrYoYQoQ Mar 2026Dec 2025Mar 2025
Sales —— 0.00.00.0
Operating profit loss narrowedloss widened -0.2-0.2-0.2
Other income -33.3%+100.0% 0.00.00.0
Net profit loss narrowedloss widened -0.2-0.2-0.2
EPS (₹) loss narrowedloss widened -0.21-0.19-0.22

Quality of profit

Pre-tax profit −₹0.2 Cr: core business −₹0.2 Cr, other income ₹0.0 Cr.

Core profit YoY: loss narrowed

Cash & debt

FY26 cash from operations ₹0.1 Cr.

Borrowings ₹0.5 Cr at Mar 2026.

How to read this page

The numbers. Each card is one company's Q4 FY26 results as filed with NSE or BSE, read from the filing within hours of its release, in ₹ crore. We show the consolidated statement, or the standalone one when the consolidated figures are a copy of it or have no year-ago quarter to compare with. YoY compares with the same quarter a year earlier and QoQ with the quarter before (the previous half-year for companies that report every six months). A swing between profit and loss is described in words: a percentage across it would mislead.

Net profit. On a consolidated statement, net profit is the profit of the whole group for the quarter, before minority interest. A company's own headline, and the AI read of its filing, often quote the profit attributable to its shareholders instead, which is lower when subsidiaries are partly owned: Larsen & Toubro's Q1 FY27 group profit was ₹4,988 Cr, of which ₹4,123 Cr belonged to its shareholders. EPS is worked out on that attributable profit, so EPS and net profit need not grow at the same rate. On a standalone statement the two are the same.

Margins. Operating margin (OPM) is operating profit, before depreciation, interest and other income, as a share of sales; PAT margin is net profit as a share of sales. Their changes are in basis points (100 bps = 1 percentage point).

Quality of profit. Core profit is operating profit minus interest and depreciation: what the business itself earned before tax. The rest of pre-tax profit is other income (interest on cash, dividends, gains on investments) and exceptional or one-off items. We flag a quarter when that share is 25% or more, and when reported profit grew much faster than core profit. For banks we compare pre-provision profit with net profit, since a fall in provisions can lift profit without the business growing.

Against its own trend. We do not have analyst consensus estimates, and we do not make them up. Instead each company is measured against the path it was on: the same quarter last year, grown at the median of its last four year-on-year growth rates (held between −50% and +100%; at least two growth rates needed). Sales 5% or more above that, or net profit 10% or more above, is "above trend"; as far below is "below trend". It answers "was this quarter better or worse than the company's own recent run?", which consensus does not.

Cash and debt. Profit is an accounting figure; cash is harder to dress up. For each company we show its operating cash flow for the last financial year as a share of that year's net profit (flagged under 50%, or when it is negative despite a profit), and its borrowings at the latest balance sheet against the one six months earlier (flagged at a 25% move). Balance sheets come with the September and March results, the year's cash-flow statement with the March results and the half-year's (April to September) with the September results.

Management guidance. When a company files the transcript of its earnings call, we read what its management said to expect: revenue or profit growth, margins, capex and the like, for this financial year or part of it. A figure is kept only when the sentence that states it is found in the transcript, and you can read it under "What management said". Growth and margins are then set beside the actual so far: the year-to-date quarters against the same quarters a year earlier (so the first half is measured against a full-year figure). Within 1 percentage point of the range for growth, or 0.5 for margins, is "on track"; above it "ahead", below it "behind". A new figure for the same period is marked raised or cut against the one before. This is what management said, not a forecast of ours.

Working capital. Inventory, trade receivables and trade payables from the same balance sheets, each also as days of sales (the amount against the twelve months' sales to that date, times 365). Receivables or inventory that grow 25 points or more faster than sales between two balance sheets (and by at least 20%) are flagged: money tied up in customers and stock is profit not yet in cash. These lines are read from filings since the September 2026 results, so comparisons with an earlier balance sheet start with the March 2027 results for most companies.

Price since results. The latest close against the last close before the filing (a filing after 3:30 pm counts from the next session). It is a fact about the market's reaction, not advice.

Market cap groups. Large cap is the 100 largest companies by market value and mid cap the next 150 (SEBI's ranking); below that, small cap is ₹5,000 Cr or more, micro cap ₹500 Cr or more, nano cap below.

⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI